CD40LG and infection: In particular, when analyzing the sensitivities for all biomarkers according to primary (NS1/IgM/IgG-) and secondary infections (NS1/IgM/IgG+), the CareUS kit had statistically different (p <0.05) sensitivities of 59.09 and 95.40%, respectively.